Recurrent herpes simplex (recurrent labial and facial herpes, recurrent genital herpes)
Conditions
Interventions
None listed
Sponsors
Sugai Junichi
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: (1) Men and women >= 18 years old at the time of registration*1 (2) Patients who have a history of outpatient visits to the research institution for treatment of recurrent herpes simplex (recurrent herpes on the lips and face, recurrent genital herpes) (3) Patients who have continued 5-day treatment with oral antiherpes virus drugs for one year or more for the treatment of recurrent herpes simplex (4) Patients whose treatment method was changed from 5-day treatment with oral antiherpes virus drugs to PIT treatment with famciclovir at the research institution (5) Patients who have continued Famciclovir PIT treatment at a research institution for one year or more (6) Patients who have consecutive treatment periods for (3) and (5) (7) Patients who can confirm the number of recurrences of recurrent herpes simplex in the past one year from the time of registration (8) Patients whose annual number of recurrences of recurrent herpes simplex during the period of PIT can be confirmed (9) Patients who did not indicate their refusal to opt-out *1 The date when famciclovir was first prescribed to the target patient for PIT
Exclusion criteria
Exclusion criteria: Paciants judged to be inappropriate by the principal investigator
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Comparison of number of recurrences (times/year) during period 1 and the first year of period 2 | — |
Secondary
| Measure | Time frame |
|---|---|
| Comparison of number of recurrences (time/year) during the first year and the second year of period 2(In Period 2, only pacients who have been observed for 2-year or longer) | — |
Contacts
Public ContactJunichi Sugai
Sugai Dermatology Park Side Clinic
Outcome results
None listed